60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 63.90% | 106.84% | 202.12% | 128.69% | 118.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.90% | 106.84% | 202.12% | 128.69% | 118.37% |
| Cost of Revenue | -48.75% | -46.92% | -35.63% | -31.11% | 520.45% |
| Gross Profit | 68.35% | 69.25% | 62.93% | 52.35% | -812.95% |
| SG&A Expenses | 14.28% | 25.70% | 26.18% | 18.20% | 24.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.49% | -11.82% | -7.25% | -7.40% | 87.46% |
| Operating Income | 22.76% | 20.14% | 17.16% | 13.94% | -85.41% |
| Income Before Tax | 26.12% | 7.38% | -0.31% | -383.23% | -1,201.99% |
| Income Tax Expenses | 100.00% | -- | 11.11% | 42.86% | -125.00% |
| Earnings from Continuing Operations | 26.12% | 7.38% | -0.32% | -383.14% | -1,201.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -52.17% | -62.79% | -82.90% | -86.13% | -87.01% |
| Net Income | 26.10% | 7.32% | -0.72% | -397.33% | -1,294.74% |
| EBIT | 22.76% | 20.14% | 17.16% | 13.94% | -85.41% |
| EBITDA | 23.22% | 20.58% | 17.56% | 14.28% | -85.86% |
| EPS Basic | 91.17% | 85.32% | 87.46% | -327.82% | -216.55% |
| Normalized Basic EPS | 91.44% | 85.31% | 87.27% | 83.29% | 17.14% |
| EPS Diluted | 91.17% | 85.32% | 87.46% | -327.82% | -216.55% |
| Normalized Diluted EPS | 91.44% | 85.31% | 87.27% | 83.29% | 17.14% |
| Average Basic Shares Outstanding | 456.66% | 488.92% | 671.51% | 652.36% | 724.30% |
| Average Diluted Shares Outstanding | 456.66% | 488.92% | 671.51% | 652.36% | 724.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |